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Abstract
Background: Operational/implementation research (OR/IR) is a key activity to improve disease control programme
performance. We assessed the extent to which malaria and tuberculosis (TB) grants from the Global Fund to Fight
AIDS, Tuberculosis and Malaria (“Global Fund”) include support for OR/IR, and discuss the implications of the current
Global Fund operating mechanisms for OR/IR support.
Methods: The situation analysis focussed on malaria and TB, while HIV was excluded. Stakeholder interviews were
conducted at the Global Fund secretariat and in six purposefully selected high disease burden countries, namely the
Democratic Republic of the Congo, Ethiopia, India, Indonesia, Myanmar and Zimbabwe. Interviewed in-country
stakeholders included the relevant disease control programme managers, project implementation partners,
representatives from international organisations with a stake in global health, academic and governmental research
institutions, and other relevant individuals such as members of the country coordination mechanism. Additionally,
documentation of grants and OR/IR obtained from the Global Fund was reviewed.
Results: The Global Fund provides substantial resources for malaria and TB surveys, and supports OR/IR if such support
is requested and the application is well justified. We observed considerable variations from one country to another and
between programmes with regards to need, demand, absorption capacity and funding for OR/IR related to malaria
and TB. Important determinants for the extent of such funding are the involvement of national research coordination
bodies, established research agendas and priorities, human and technical research capacity, and involvement of
relevant stakeholders in concept note development. Efforts to disseminate OR/IR findings were generally weak, and the
Global Fund does not maintain a central OR/IR database. When faced with a need to choose between procurement of
commodities for disease control and supporting research, countries tend to seek research funding from other donors.
The Global Fund is expected to issue more specific guidance on the conditions under which it supports OR/IR, and to
adapt administrative procedures to facilitate research.
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Conclusions: The importance of OR/IR for optimising disease control programmes is generally accepted but countries
vary in their capacity to demand and implement studies. Countries expect guidance on OR/IR from the Global Fund.
Administrative procedures specifically related to the budget planning should be modified to facilitate ad-hoc OR/IR
funding. More generally, several countries expressed a need to strengthen capacity for planning, negotiating and
implementing research.
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Background
A number of proven standard interventions for control-
ling priority diseases in low- and middle-income countries
(LMICs) exist, for example the large-scale distribution of
insecticide-treated bed nets and ambulatory treatment of
tuberculosis (TB) patients. At the same time, the effective
implementation of these interventions requires adaptation
to specific contexts, highlighting the importance of oper-
ational and implementation research (OR/IR) [1–4].
Indeed, an important aim of OR/IR is to provide an evi-
dence base for context-specific implementation of globally
proven interventions and to identify issues that prevent
programmes from operating effectively, thereby providing
evidence-based solutions for improving programme per-
formance [5–8]. OR/IR intends to generate locally rele-
vant answers and solutions that can be used by a specific
programme but evidence may also be relevant far beyond
[9, 10]. It is well documented that policy-making and
decision-taking are not always evidence-based although
local evidence is arguably the most compelling [11, 12]. It
is the understanding of many global health stakeholders,
including the Special Programme for Research and Train-
ing in Tropical Diseases (TDR), that OR/IR should be an
integral part of disease control programme activities to
maximize their outcome and impact [13–15].
The present article analyses the role that OR/IR plays
for optimising programme performance of international
health assistance through the example of the Global
Fund to Fight AIDS, Tuberculosis and Malaria (“Global
Fund”). Of note, the Global Fund is the single largest
external funder of control programmes targeting TB and
malaria in LMICs [16]. In 2008, the Global Fund – to-
gether with TDR – started to promote the inclusion of
OR/IR activities in disease control programmes it sup-
ports. These efforts were linked to the development of a
series of relevant guidelines, frameworks and toolkits
[17–19]. The active promotion of OR/IR was subse-
quently reduced, and the extent to which countries cur-
rently request Global Fund support for OR/IR remains
unclear. In 2011, the Global Fund introduced the “New
Funding Model” which, among others, provides guide-
lines on the proven priority interventions eligible for
Global Fund support. While the most recent version of
these guidelines provides a detailed description of the
scope of eligible interventions, hardly any reference is
made to OR/IR and the role research may play for deal-
ing with context-specific implementation problems [20].
More generally, the mechanisms determining to what
degree countries take advantage of OR/IR funding are
not well documented, let alone understood [1].
We conducted a situation analysis with the goal to
deepen the understanding of the extent to which OR/IR
activities are included in Global Fund grants and the de-
terminants resulting in the observed patterns. Emphasis
was placed on malaria and TB, while HIV was excluded.
High disease burden countries in Africa and Asia receiv-
ing significant and sustained support by the Global Fund
were purposefully selected to represent a range of condi-
tions. The specific objectives of the situation analysis were:
(1) to assess the extent to which Global Fund grants are
being utilized to support OR/IR projects and activities; (2)
to understand the context, funding sources, capacities,
challenges and considerations regarding OR/IR within the
selected countries; (3) to explore the priority that different
stakeholders in-country and at the Global Fund give to
OR/IR; and (4) to identify gaps, priorities and potentials
that can be activated in the short- and medium-term.
Methods
Study approach
The situation analysis was conducted in the second half
of 2015. A mixed methods approach was chosen, con-
sisting of a review of key documents as well as inter-
views with a broad range of stakeholders. The data
collection included five main activities: (i) review of pub-
licly available documents pertaining to OR/IR and the
Global Fund; (ii) review of publicly available (deadline:
September 2015) grant proposals for the six selected
countries; (iii) analysis of grant budgets made available
to the research team by the Global Fund; (iv) interviews
with representatives from the Global Fund (the fund
portfolio manager (FPM) and/or respective country
teams); and (v) interviews with in-country key infor-
mants from different stakeholder groups.
Country selection
The selection of the study countries was based on the
following criteria: (i) high malaria and TB burden; (ii)
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representation of different geographic regions; and
(iii) Swiss Tropical and Public Health Institute (Swiss
TPH; Basel, Switzerland) not acting as a Local Fund
Agent in the country. Three countries in Africa
(Democratic Republic of the Congo, Ethiopia and
Zimbabwe) and three in Asia (India, Indonesia and
Myanmar) were selected.
Document review
The document review consisted of three sequential steps.
First, a search on the Global Fund website was conducted
to identify key documents on OR/IR and support of such
activities through Global Fund grants. Second, all publicly
available Global Fund proposals from Round 1 up until
and including the New Funding Model that had been
submitted by the six study countries were obtained and
screened for evidence of OR/IR using the keywords
‘research’, ‘study’ and ‘studies’. Initially, the identified
paragraphs were differentiated between ‘OR/IR’ or ‘other
research’ based on the context. OR/IR-related paragraphs
were classified into three categories: (1) epidemiological,
behavioural and knowledge, attitude and practices (KAP)
studies, and household and health facility surveys; (2)
capacity building and training in OR/IR; and (3) support
for the establishment of national research agendas and
OR/IR review committees. Third, the available budgets
were analysed with regards to the proportions spent on
monitoring and evaluation (M&E) and specifically OR/IR.
Stakeholder interviews
Interviews with key stakeholders were conducted by the au-
thors at the Global Fund secretariat (one per country) and
during visits in all study countries. At the Global Fund, the
FPM and/or other country team members participated in
the interview, either face-to-face or by phone. A semi-
structured questionnaire guided the interview which
addressed the following topics: (i) attitudes towards OR/IR
and related experiences at the Global Fund; (ii) strategic
perspectives on OR/IR, including funding tendencies and
outlook on its relevance; (iii) barriers and challenges for
successful application for, and implementing of, OR/IR; and
(iv) any complementary information that might be of
relevance. Answers were categorized according to pre-
determined terms (for example yes/no; stakeholder type) or
as suggested by interviewees (for example perceived OR/IR
capacity), with explanations and answers to open questions
captured in writing during the interviews. Once completed,
the key points and messages of the interview were sum-
marised and shared with the respondents for validation.
In-country, interviews were conducted face-to-face or
by telephone, as appropriate. Respondents represented the
following stakeholder groups: country coordinating mech-
anism (CCM), principal recipients and sub-recipients of
Global Fund grants, national disease control programme
managers, M&E and research coordinators, other project
implementation partners, academic and governmental
research institutions and international organizations with
a stake in global health (Table 1). The following topics
were addressed by the semi-structured interview guide: (i)
national OR/IR policies and available funding; (ii) organi-
sations/partners involved in OR/IR related to Global
Fund-supported projects; (iii) capacities and challenges for
OR/IR; (iv) dissemination of results of OR/IR and know-
ledge management; (v) missed opportunities and promis-
ing topics for OR/IR; and (vi) tendencies and suggestions
for future OR/IR. The questionnaires are available as Add-
itional files 1 and 2.
The interviews were analysed by reviewing the an-
swers to specific topics across respondents with a focus
on the detection of patterns that could be linked to
respondent characteristics (for example function, repre-




Key documents on OR/IR were typically co-authored by
the Global Fund, TDR, the World Health Organization
(WHO) and other organisations [17–19, 21]. Advice on
the integration of OR/IR in Global Fund grants was first
published in 2007. The document emphasises the im-
portance of OR/IR for improving programme perform-
ance and outcomes and encourages applicants to
earmark Global Fund resources for this purpose [17]. A
guide published in 2008 further underscores the import-
ance of OR/IR and explains relevant administrative pro-
cedures [18]. It states that “Everyone writing a Global
Fund application, and anyone concerned with improving
their program’s performance, should think about whether
OR should be built into the application. […] Global Fund
supported programs are recommended to spend 5-10% of
their grant budget on M&E, which can include spending
on relevant OR” [18]. In 2009, a framework was
Table 1 Number of stakeholder interviews on OR/IR within Global
Fund grants, stratified by respondent type and study country







2 7 6 2 17
Ethiopia 1 3 4 7 15
India 1 6 2 0 9
Indonesia 1 7 3 5 16
Myanmar 0 5 1 1 7
Zimbabwe 3 4 5 6 18
Total 8 32 21 21 82
CCM country coordinating mechanism, NP national programme, PR principal
recipient, SR sub-recipient
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published for the planning and implementation of OR/
IR in health and disease control programmes, including
a collection of case studies [19]. OR/IR is also men-
tioned in the most recent M&E guidance issued by the
Global Fund [21]. Taken together, these publications
document a consistent and positive appreciation for OR/
IR by the Global Fund. However, in the instructions and
templates for the New Funding Model, no reference is
made to any of the aforementioned documents and OR/
IR is not explicitly featured [22, 23].
OR/IR in grant proposals
A total of 49 Global Fund grant proposals and concept
notes were available for in-depth analysis (Table 2). Para-
graphs mentioning OR/IR were identified in 92.0% of
them. From the six countries analysed, most statements
(54.7%) were related to epidemiological, KAP and behav-
ioural studies and surveys of households and health facil-
ities. Capacity building and OR/IR training was most
prominent in proposals from Indonesia (21% of all rele-
vant statements), while it featured rarely in the pro-
posals submitted by the remaining five countries. Only
a single statement concerning the establishment of na-
tional research agendas and review committees could be
identified. A substantial number of references to OR/IR
(34.0%) could not be classified into any of the predefined
categories as they were too broad or did not mention a
specific research focus or content.
OR/IR and budgets
A total of 20 grant budgets from Round 6 up to the New
Funding Model were available for review. Considerable
variations between countries, diseases and grants were
observed with regards to the allocation of funds to M&E
and OR/IR. The level of detail also varied across bud-
gets, from very general statements such as ‘funding for
OR’ to more specific headings like ‘conduct OR in xxx
provinces to determine factors contributing to high death
rate among yyy patients as well as other studies to be
determined from the research agenda’. Sometimes, the
costs for different activities were detailed. According to
the available budgets, between 3.5 and 39.0% of the
M&E budget was dedicated to OR/IR.
Stakeholder interviews
Awareness and significance of OR/IR
Key informants at the Global Fund stated that OR/IR can
help to identify bottlenecks in programme implementa-
tion leading to possible solutions. The relevance of OR/IR
studies to better understand programme performance and
improve outcomes was less clear. The importance of
large-scale and representative surveys (for example a
Malaria Indicator Survey (MIS)), hence not typical OR/IR,
was widely appreciated.
In-country stakeholders identified the generation of
evidence on the effectiveness of an intervention and the
need to enhance programme performance as main moti-
vations to conduct research and specifically OR/IR. The
majority of the respondents acknowledged the relevance
of OR/IR to improve disease control programmes and
were aware of the possibility to include OR/IR projects
in Global Fund grant proposals.
Opinions were divided with regards to Global Fund
concept note development: while some perceived the
content to be country-driven, others felt it was donor-
driven. The main perceived barriers to apply for OR/IR
funding were: (i) limited overall funding, which leads to
prioritization of curative and preventive services over
OR/IR; (ii) available complementary funding for OR/IR
from other sources; (iii) lack of a well-defined research
agenda; (iv) limited involvement of academia during
concept note development and data collection activities;
(v) incompatibility of research and programme imple-
mentation, particularly the lengthy planning, approval
and sometimes data collection necessary to conduct
research; (vi) administrative hurdles as OR/IR needs are
often vague at the time of proposal writing and later
budget modifications are perceived as cumbersome;
(vii) medium- to long-term time horizon for programme
performance improvement through OR/IR conflicting
with need for more immediate results; and (viii)
interest of the Global Fund in OR/IR not clear to all
stakeholders.
Table 2 Number of Global Fund proposals available for review, stratified by type of statements referring to OR/IR and country
Democratic Republic of the Congo Ethiopia India Indonesia Myanmar Zimbabwe Total
Reviewed proposals (n) 10 9 10 8 6 6 49
Statements on OR/IR (n) 41 29 38 22 6 26 162
Category 1 (%) 73.0 45.0 34.0 91.0 33.0 58.0 54.7
Category 2 (%) 7.0 21.0 5.0 9.0 0.0 0.0 7.9
Category 3 (%) 0.0 0.0 3.0 0.0 0.0 0.0 0.0
No specific information (%) 20.0 34.0 58.0 0.0 67.0 42.0 34.0
Category 1, epidemiological, KAP and behavioural studies and surveys of households and health facilities; Category 2, capacity building and training in OR/IR;
Category 3, establishment of national research agendas and review committees
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Funding of OR/IR
According to the interviewed Global Fund representatives,
the inclusion of OR/IR in proposals and budgets is usually
not actively promoted by the Global Fund and the relative
prominence of OR/IR in different countries and proposals
is mainly determined by the CCM. Key informants empha-
sised that countries can request funding for OR/IR studies
in the frame of proposals/concept notes [21], but that the
applicants are expected to take the initiative. During grant
negotiations the country team of the Global Fund may try
to influence the inclusion of OR/IR studies. During grant
implementation, FPMs indicated that they would con-
sider modest requests for budget reallocations to ac-
commodate emerging needs for OR/IR but that the
approval of such requests depended heavily on the pro-
posed research and the perceived capacities in-country.
This approach became entrenched since previous initia-
tives to streamline OR/IR handling across country
teams, for example an institutional focal point for OR/
IR or an inventory of all OR/IR studies funded by the
Global Fund, are no longer pursued.
By 2015, the Democratic Republic of the Congo, Ethiopia
and India had research agendas including OR/IR activities
for both malaria and TB. Indonesia and Myanmar had
identified a need for OR/IR only for the latter disease. Of
note, substantial funding through a regional grant was
available for malaria-related research in Myanmar (Re-
gional Artemisinin Initiative (RAI)). Only Zimbabwe
had not planned OR/IR activities pertaining to TB or
malaria at the time of data collection. Stakeholders
identified the Global Fund as a leading funder of large-
scale surveys like Demographic and Health Surveys
(DHS), MIS, and TB prevalence and mortality surveys,
but small-scale OR/IR studies were often funded from
other sources. The majority of the interviewees per-
ceived the funding earmarked for OR/IR within Glo-
bal Fund grants as too low considering the scarce
national funding sources for research. Only in India
the government allocated significant funds to re-
search. Respondents with a history of conducting OR/
IR supported by the Global Fund reported positive
experiences. However, not all requests had been ap-
proved: key informants in the Democratic Republic of
the Congo, Myanmar and Zimbabwe indicated that
funding applications for OR/IR had been rejected in
the past, and speculated that this might have been
linked to perceived or real limitations in in-country
capacities to implement research.
Implementation of OR/IR
The Global Fund representatives observed considerable
diversity between countries and programmes with regards
to the priority allocated to OR/IR and capacity to propose
and implement OR/IR. Key informants felt that these
variations could be due to (i) country priorities; (ii) imple-
mentation status of programmes; (iii) interest and influ-
ence of different stakeholder groups; (iv) available in-
country capacity; (v) programme structures; (vi) bureau-
cratic barriers; (vii) difficulties in budgeting; and (viii)
preference for funding commodities through Global Fund
in the light of available alternative funding sources for OR/
IR. The perception of the degree of their influence on coun-
try priorities, including the promotion of OR/IR, varied.
The main implementers of OR/IR studies funded through
Global Fund grants were the Ministries of Health (MoH).
Non-governmental organisations (NGOs) and academic in-
stitutions were also involved (Table 3). A main bottleneck
identified by many in-country key informants was research
capacity, specifically technical capacity (for example re-
search methods), time and funding (Table 4). Technical
capacity has often been reported to be concentrated within
selected institutions (for example government research in-
stitutes and academic institutions), resulting in qualified
staff and technical capacities being heavily centralised in
the capital cities. Almost all interviewees indicated that the
institutions planning or conducting OR/IR studies received
technical assistance, often provided by international consul-
tants or organisations (for example the WHO, United
States Agency for International Development (USAID)/
President’s Malaria Initiative (PMI), The Union Against
Tuberculosis and Lung Disease (The Union), United
Nations Children’s Fund (UNICEF)) but at times also
by national institutions such as universities.
Coordination of OR/IR activities
In-country coordination of OR/IR was typically seen
as the responsibility of either the MoH or disease-
specific control programmes. Sometimes, the task had
been delegated to a dedicated working group (Table 4).
Important variations between countries and disease
control programmes were observed with regard to govern-
ance structures. For example, in Indonesia, the Tubercu-
losis Operational Research Group was a well-established
coordinating body but no comparable counterpart existed
for malaria. In Ethiopia, both national TB and malaria
programmes had established research coordination bodies;
however, human resources constraints meant that their
relevance was limited. In Myanmar, the coordination,
execution and oversight over research is centralised in the
Department for Medical Research of the Ministry of
Health and Sports, while Zimbabwe lacks coordinating
bodies. Results dissemination was only regulated in
Myanmar and the lack of central data repositories was
identified as an important weakness by the respondents.
Suggestions regarding OR/IR within Global Fund grants
A number of opportunities to address issues through
integration of OR/IR into grants were mentioned by
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Global Fund representatives. However, as the organisa-
tion considers grants to be driven by country priorities,
the countries and organisations with a stake in technical
assistance and the development of disease-specific global
guidance such as WHO and its country offices are
judged to be in a better position than the Global Fund
to suggest concrete OR/IR activities. The interviewed
key informants agreed that earmarking a fixed percent-
age of the budget for OR/IR should be avoided, but
that more budget flexibility would encourage coun-
tries to apply for more OR/IR studies. For instance, it
was repeatedly suggested that, based on the countries
research capacities, an appropriate amount should be
reserved in the budget to cover emerging OR/IR
needs, thus eliminating the need for formal budget
re-allocations.
The main suggestions with regard to strengthening the
position of OR/IR in Global Fund grants that were iden-
tified by the in-country respondents were: (i) wide dis-
semination of results and efforts to facilitate the uptake
of research evidence by policy makers; (ii) better co-
ordination between different institutions involved in
disease control programmes and OR/IR; (iii) more in-
clusive approach in the concept note development
process, specifically the systematic involvement of the
OR/IR research community; (iv) building of research
capacity; and (v) raising general awareness for the
value of research. Respondents, particularly those with
experience in OR/IR funding by the Global Fund, in-
dicated that they missed specific guidance and encour-
agement by the Global Fund to include OR/IR activities in
grants. Their suggestions to the Global Fund included: (i)
provision of guidance on OR/IR inclusion; (ii) ensuring in-
volvement of research institutions/academia in concept
note development and drafting of OR/IR studies; (iii)
coordination of OR/IR studies at Global Fund level to effi-
ciently identify and address important knowledge gaps;
(iv) Global Fund to request countries to outline oper-
ational and implementation challenges and suggestions to
manage them; (v) support for national or disease-specific
research coordination bodies to facilitate OR/IR and
increase country ownership; (vi) facilitation of regional
and global exchange of OR/IR findings; and (vii) align-
ment of funding and administration guidelines with stand-
ard research procedures.
Interviewees identified the following types of studies
and topics as most important for optimizing programme
implementation and grant performance: malaria and TB
prevalence studies, improved service provision to migrant
and hard-to-reach populations, drug resistance monitoring
and mitigation strategies, malaria elimination strategies,
introduction of new diagnostics, and long-lasting insecti-
cidal nets preferences and use.
Discussion
The Global Fund provides detailed guidance on eli-
gible interventions under the New Funding Model,
emphasises the essential role of M&E systems but
does not specifically refer to the role that OR/IR may
play in identifying context-specific solutions to imple-
mentation challenges. The Global Fund is a central
funder with ramifications for the strengthening of
Table 3 Perceived OR/IR capacity according to in-country key informants, stratified by country
Capacity… Democratic Republic of the Congo Ethiopia India Indonesia Myanmar Zimbabwe Total
…to identify OR/IR research questions (n) 10 13 7 11 6 14 61
Low (%) 30.0 8.0 0.0 27.0 33.0 21.0 19.6
Medium (%) 60.0 46.0 0.0 27.0 67.0 36.0 39.4
High (%) 10.0 46.0 100.0 45.0 0.0 43.0 41.0
…to develop study protocols (n) 12 13 7 10 6 11 59
Low (%) 42.0 15.0 0.0 20.0 17.0 9.0 18.6
Medium (%) 42.0 46.0 29.0 50.0 50.0 36.0 42.4
High (%) 17.0 38.0 71.0 30.0 33.0 55.0 39.0
…to conduct/implement OR/IR projects (n) 11 13 7 17 10 12 70
Low (%) 45.0 31.0 0.0 53.0 10.0 17.0 30.0
Medium (%) 45.0 46.0 57.0 29.0 20.0 33.0 37.0
High (%) 9.0 23.0 43.0 18.0 70.0 50.0 33.0
…to coordinate and oversee OR/IR projects (n) 12 13 7 11 6 4 53
Low (%) 50.0 15.0 0.0 64.0 33.0 0.0 32.0
Medium (%) 42.0 54.0 43.0 9.0 0.0 50.0 34.1
High (%) 8.0 31.0 57.0 27.0 67.0 50.0 33.9
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health information systems and implementation of
large-scale population-representative surveys pertain-
ing to malaria, TB and HIV/AIDS [24, 25]. Basic and
general research as well as individual career develop-
ment grants, on the other hand, cannot be supported
by the Global Fund. However, the Global Fund is
committed to fund OR/IR studies that directly ad-
dress operational questions and aim at identifying prac-
tical solutions to implementation bottle-necks with a
view to optimize programme performance and out-
comes. Exceptionally, it also supports thematic grants,
which may include substantial research agendas such as
the RAI that aims at interrupting the spread of artemi-
sinin resistance in the Greater Mekong sub-region
through a high coverage with long-lasting insecticidal
nets, improved diagnosis and treatment, as well as
strengthened surveillance.
A key finding of the current situation analysis is that
there are large variations in the demand and absorption
capacity for OR/IR and consequently also in available
funding across the countries and programmes
reviewed here. The following determinants for OR/IR
related to national malaria and TB control pro-
grammes were identified: availability of a national or
disease-specific research strategy, particularly one
that emphasises the value of OR/IR, in-country hu-
man and technical research capacity, access to local
and international technical assistance, coordination of
research activities by a designated body, and involve-
ment of all relevant stakeholders including research
institution representatives in the concept note devel-
opment. Of note, research needs as well as resource
availability are often not well mapped out, and prior-
ities may be poorly aligned. Similarly, a challenge
Table 4 Research coordinating bodies, main OR/IR study implementers and key OR/IR funders, stratified by country
Country Research coordinating body Main implementers Main funders
Democratic Republic
of the Congo
TB: National TB programme
Malaria: No official body. Stakeholders
mentioned different coordination
structures. Current ongoing establishment
of a coordinating structure within the
“Comité Scientifique”.
Ecole de Santé Publique (ESP),
Department of Tropical Medicine,
Centre National de Pharmacovigilance
and the Institut National de Recherches
Biomédicales (all associated with
Kinshasa University), Swiss TPH
Global Fund, Presidents Malaria
Initiative/USAID/Centers for Disease
Control, Department for International
Development, the World Bank,
European Union, UNICEF, NGOs and
foreign universities
Ethiopia TB: National TB Research Advisory
Committee (TRAC)
Malaria: Malaria Research Network of
Ethiopia (MRNE)
The Ethiopian Public Health Institute (EPHI)
has the mandate to coordinate research
activities in the area of health but currently
has insufficient human resources
Ethiopian Public Health Institute, local
health authorities, universities
Global Fund, USAID
India TB: Central TB Division, Ministry of Health
and Social Welfare (MoHSW)
Malaria: Central Malaria Division, Ministry
of Health and Social Welfare; National
Institute of Malaria Research; National
Vector-Borne Disease Control Programme
The disease control programmes maintain





Indonesia TB: TB Operational Research Group (TORG)
Malaria: Development of a structure similar
to the TORG is ongoing. The coordination
of OR for malaria is currently with the
National Malaria Control Programme (NMCP)
University of Gadjah Mada, Padjadjaran
University, University of Indonesia,
National Institute of Health Research
Development, Eijkman Institute
Global Fund, Government of
Indonesia, USAID/KNCV
Myanmar TB: Department for Medical Research (DMR)
Malaria: DMR
The DMR is overseeing and coordinating
all research activities in the country
Department for Medical Research,
University of Maryland, Mahidol
University (Shoklo Malaria Research
Unit), Malaria Consortium, Population
Services International
Global Fund (directly and through RAI)
3 Millennium Development Goal Fund,
USAID, Presidents Malaria Initiative
Greater Mekong Subregion Malaria




The National Institute of Health Research
(former Blair Institute) has the mandate to
coordinate research activities in the area
of health but its current focus is on
implementation of malaria research
BRTI (local NGO), universities, local
health authorities, The Union,
National Institute of Health Research
Global Fund, USAID
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appears to be the process of results dissemination,
both in-country to policy makers and across coun-
tries. Last, no central database of OR/IR studies sup-
ported by the Global Fund exists, and hence, it is
difficult for country teams to locate examples for
proposed studies, take previous results into account,
and learn from prior experience. The country teams
of the Global Fund are not actively involved in con-
cept note development as this is a country-driven process.
However, interviewed in-country stakeholders expressed a
wish for feedback and guidance regarding OR/IR by the
Global Fund. It is conceivable that the findings from a
specific country can be extended to other diseases
within that country but no conclusions regarding the
situation in countries not covered in this study can
be made, as illustrated by the considerable variation
between study countries.
Reportedly, proposing concrete OR/IR studies at
the time of concept note development is often not
feasible since operational challenges typically only be-
come apparent during project implementation. While
this argument is relevant for disease control pro-
grammes that are implemented over an extended
period by the same in-country organisations, it might
point towards an insufficient documentation of imple-
mentation challenges over the years, or inadequate in-
volvement of relevant stakeholders in the concept note
development. The results and outcome-driven funding
model operated by the Global Fund means that OR/
IR studies should directly contribute to improved
programme performance under the same grant to be
fully justified. This demand is not fully compatible
with traditional research approaches under which
study results are first published in academic circles
and expected to be reviewed in the light of other
studies to ultimately impact policy while direct feed-
back to relevant stakeholders is less well established.
The present situation analysis revealed that OR/IR was
better integrated into grants and more prominently
represented in countries with (a) an established research
coordination body [26–30]; (b) a strong autochthonous
capacity to design and implement research projects; (c)
an inclusive approach to concept note development; and
(d) a country team at the Global Fund secretariat with
an active interest in integrating OR/IR studies into
grants. Importantly, countries appear to often make a ra-
tional choice when confronted with the question of
whether or not to include requests for support for OR/
IR studies in Global Fund grant applications. Important
considerations in the process are budget restrictions and
the availability of alternative funding sources for OR/IR:
the needs of the programme and the chances or approval
are carefully assessed to maximise overall support, and as
a result countries may opt to obtain a maximum of
commodities and operational support through Global
Fund grants, while funding for OR/IR is obtained from
other sources with different funding priorities.
Our situation analysis has a number of shortcom-
ings that are offered for consideration. First, a com-
parable representation of different stakeholders was
sought for all countries and country teams at the
Global Fund secretariat but the total number of inter-
views per country and the profiles of the interviewees
varied slightly depending on the availability of poten-
tial respondents and the situation in-country. Second,
as in all studies primarily relying on self-reported in-
formation, a certain bias due to the background and
personal interest of the respondents and their aware-
ness of the study objectives cannot be excluded.
Third, the availability and detail of grant proposals
and budgets varied, and their screening with a unified
set of keywords may have resulted in the erroneous
exclusion of relevant items if a different wording had
been used. Finally, no conclusions can be drawn regarding
HIV-related grants since these were excluded from the
study. However, there is no indication that the Global
Fund systematically applies a different OR/IR policy to
HIV as opposed to malaria and TB.
Table 5 Recommendations
Global Fund secretariat
• Global Fund to provide specific guidance on inclusion of OR/IR in
concept notes and grant budgets.
• Global Fund to ensure necessary flexibility to fund small-scale OR/IR
studies identified only after grant signing, e.g. through flexible OR/IR
allocation within the M&E budget.
• (Re-)establishment of an inventory of OR/IR studies supported by the
Global Fund.
Technical partners
• Technical partners including WHO country and regional offices to
promote and actively support the inclusion of OR/IR in country
health strategies, strategic development plans, guidance documents
and disease-specific agendas to increase awareness and to align Global
Fund concept notes including OR/IR studies with all relevant guidance.
Countries
• Countries to increase awareness of the importance of OR/IR within
national disease control efforts and inclusion of OR/IR in concept
note development. Hence, academic and research stakeholders
should be closely involved in the elaboration of concept notes.
• Countries to strengthen capacities at all levels to coordinate research,
develop research agendas as well as to plan, conduct, oversee and
disseminate OR/IR. Improve communication strategies to disseminate
findings to relevant stakeholders to influence policy and translate
findings into improved program performance.
• Countries to improve results dissemination and uptake in-country,
and – with support from funders and development partners –
facilitation of results dissemination across programs and countries
(e.g. regional).
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Conclusions
Demand and significance of OR/IR vary from one
country to another, mainly determined by in-country
capacities to coordinate and implement studies and
perceived needs. In-country stakeholders express a
desire for more specific guidance pertaining to OR/IR
from the Global Fund and more flexible administra-
tive procedures. Global Fund representatives generally
limit themselves to react to demands from countries
and focus on evidence and outcomes as main mea-
sures for success. The results of this situation analysis
informed a consultation organised by TDR in December
2015 [31] that included Global Fund representatives and
other interested stakeholders. Based on the discussions
during the stakeholder consultation, a set of recom-
mendations aimed at promoting OR/IR with the over-
arching goal to improve programme performance was
developed (Table 5). In December 2016, the Global
Fund published an Information Note that explicitly
mentions that operations research can be included in
applications to strengthen country health information
systems [32].
Additional files
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questionnaire for in-country stakeholders. (XLSX 28 kb)
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